title: Immune thrombocytopenic purpura: major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues.
authors.affiliation: Assistance publique-Hôpitaux de Paris, CHU Henri-Mondor, centre de référence des cytopénies auto-immunes de l'adulte, UPEC, 94000 Créteil, France. Electronic address: bertrand.godeau@hmn.aphp.fr.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Godeau
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000503:physiopathology* / Q000628:therapy*; D000069283:Rituximab; D013156:Splenectomy / Q000379:methods; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D010455:Peptides; C515728:thrombopoietin mimetic peptide; D000069283:Rituximab